Page 35 - Read Online

Page 28 of 28 Cheng et al. Cancer Drug Resist. 2025;8:46

169. Zheng X, Shi Y, Tang D, et al. Near-infrared-II nanoparticles for vascular normalization combined with immune checkpoint blockade
via photodynamic immunotherapy inhibit uveal melanoma growth and metastasis. Adv Sci. 2023;10:e2206932. DOI PubMed PMC
170. Zhang D, Jiang C, Zheng X, et al. Normalization of tumor vessels by lenvatinib-based metallo-nanodrugs alleviates hypoxia and
enhances calreticulin-mediated immune responses in orthotopic HCC and organoids. Small. 2023;19:e2207786. DOI PubMed
171. Feng X, Zeng L, Wu L, et al. Self-delivery nanodrug to manipulate tumor microenvironment for boosting photodynamic cancer
immunotherapy. Biomed Pharmacother. 2024;178:117220. DOI PubMed
172. Zhou Y, Ren X, Hou Z, Wang N, Jiang Y, Luan Y. Engineering a photosensitizer nanoplatform for amplified photodynamic
immunotherapy via tumor microenvironment modulation. Nanoscale Horiz. 2021;6:120-31. DOI PubMed
173. Li F, Shao X, Liu D, et al. Vascular disruptive hydrogel platform for enhanced chemotherapy and anti-angiogenesis through alleviation
of immune surveillance. Pharmaceutics. 2022;14:1809. DOI PubMed PMC
174. Zhou Z, Chen J, Liu Y, et al. Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled
albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy. Acta Pharm Sin B. 2022;12:4204-23. DOI PubMed PMC
175. Wang-Bishop L, Kimmel BR, Ngwa VM, et al. STING-activating nanoparticles normalize the vascular-immune interface to potentiate
cancer immunotherapy. Sci Immunol. 2023;8:eadd1153. DOI PubMed PMC

Disclaimer/Publisher’s Note: All statements, opinions, and data contained in this publication are solely those of the individual author(s) and
contributor(s) and do not necessarily reflect those of OAE and/or the editor(s). OAE and/or the editor(s) disclaim any responsibility for harm to
persons or property resulting from the use of any ideas, methods, instructions, or products mentioned in the content.

© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and
reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and
the source, provide a link to the Creative Commons license, and indicate if changes were made.

28